Researchers investigated how low birth weight and fetal growth restriction may result from the mother having certain variants of hypertension-related genes.
Hypertension-related genes in mothers affect infant birth weight via effects on the placenta, suggested by researchers from Tokyo Medical and Dental University (TMDU). The findings are published in BMC Medicine. Cardiovascular diseases are the leading cause of death worldwide. Although the development of these disorders is most commonly associated with lifestyle factors like obesity, increasing evidence suggests that events much earlier in one’s life can also play a role.
‘The effects on the placental vasculature are the primary factor for fetal growth restriction rather than the mother’s blood pressure at the time of pregnancy.’
Studies examining such phenomena have recently suggested that women having genes related to hypertension risk are more likely to give birth to children with low birth weight.Researchers, therefore, assumed that mothers with higher systolic blood pressure would have lower-weight newborns. However, no such association was observed.
This caused them to believe that the intrauterine environment plays more of a role in this case. They hypothesized that all of these observations were caused by effects on the placenta.
“We focused on the placenta because it is an extremely vascular organ. Placental weight also frequently correlates with birth weight,” says Noriko Sato, associate professor in the department of molecular epidemiology, who led the study.
Genome-wide association studies have shown that many blood pressure-related genes are involved in vascular system development and function.
Advertisement
Then the mediating role of the placenta regarding influence on birth weight was formally verified by the method, called a causal mediation analysis.
Advertisement
They also found an inverse association between maternal systolic blood pressure genetic risk score and the rate of fetal growth towards the end of pregnancy, specifically around 36 weeks of gestation.
These findings suggest that the maternal blood pressure-related genes are associated with undesirable fetal growth deceleration by affecting the placental growth.
Fetal growth restriction in late pregnancy occurs in more than a few percent of pregnancies, and it is mostly of unknown cause and difficult to predict.
However, incorporating maternal genetic risk information into clinical practice could enable screening and improved perinatal management for mother–child health.
Furthermore, the results contribute to the development of new therapeutic targets for the treatment and prevention of hypertension and cardiovascular diseases.
Source-Medindia